image credit: Pexels

Abbott’s OTC glucose monitor ‘will grow the market’

June 4, 2024


Abbott hasn’t issued a public statement on the 510k approval, which has just been published on the FDA’s website, but the wearable device has a similar indication to Stelo and can be used in both non-insulin-dependent type 2 diabetics as well as non-diabetics.

Like Stelo, Lingo takes the form of a patch with a tiny needle that pierces the skin and is worn on the back of the arm for a couple of weeks, communicating glucose readings to a smartphone.

Read More on Pharmaphorum